NeonKnight
New member
Either of you have plans to carry this one?
mk-677 ? for GWP and Osta
- Thread starter NeonKnight
- Start date
Osta-Marketing
New member
If there is a demand for this item we might. Can you post the research on this?
NeonKnight
New member
Just to give you an idea
U.Va. Health System Study Shows New Drug Boosts Muscle Mass in Arms and Legs of Older Adults
News Source: U.Va. Health System
November 5, 2008 ***8212; Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty.
Published in the Nov. 4 issue of Annals of Internal Medicine, the study showed that levels of growth hormone (and of insulin-like growth factor I in seniors who took MK-677 increased to the levels of those found in healthy young adults. The drug restored 20 percent of muscle mass loss associated with normal aging.
"Our study opens the door to the possibility of developing treatments that avert the frailty of aging," said Dr. Michael O. Thorner, a nationally recognized researcher of growth hormone regulation and a professor of internal medicine and neurosurgery at U.Va. "The search for anti-frailty medications has become increasingly important because the average American is expected to live into his or her 80s, and most seniors want to stay strong enough to remain independent as they age."
Funded by the National Institutes of Health, the two-year, double-blind, placebo-controlled, modified-crossover study involved 65 men and women ranging in age from 60 to 81.
The study drug, MK-677, mimics the action of ghrelin, a peptide that stimulates the growth hormone secretagogue receptor. Drug developers are focusing on that receptor because it plays an important role in the regulation of growth hormone and appetite. They think it may prove to be an excellent treatment target for metabolic disorders such as those related to body weight and body composition.
According to Thorner, the U.Va. research was a "proof-of-concept" study that sets the stage for a larger and longer clinical trial to determine whether MK-677 is effective in people who are frail and to assess its long-term safety.
This story originally appeared on the U.Va. Health System Web site.
U.Va. Health System Study Shows New Drug Boosts Muscle Mass in Arms and Legs of Older Adults
News Source: U.Va. Health System
November 5, 2008 ***8212; Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty.
Published in the Nov. 4 issue of Annals of Internal Medicine, the study showed that levels of growth hormone (and of insulin-like growth factor I in seniors who took MK-677 increased to the levels of those found in healthy young adults. The drug restored 20 percent of muscle mass loss associated with normal aging.
"Our study opens the door to the possibility of developing treatments that avert the frailty of aging," said Dr. Michael O. Thorner, a nationally recognized researcher of growth hormone regulation and a professor of internal medicine and neurosurgery at U.Va. "The search for anti-frailty medications has become increasingly important because the average American is expected to live into his or her 80s, and most seniors want to stay strong enough to remain independent as they age."
Funded by the National Institutes of Health, the two-year, double-blind, placebo-controlled, modified-crossover study involved 65 men and women ranging in age from 60 to 81.
The study drug, MK-677, mimics the action of ghrelin, a peptide that stimulates the growth hormone secretagogue receptor. Drug developers are focusing on that receptor because it plays an important role in the regulation of growth hormone and appetite. They think it may prove to be an excellent treatment target for metabolic disorders such as those related to body weight and body composition.
According to Thorner, the U.Va. research was a "proof-of-concept" study that sets the stage for a larger and longer clinical trial to determine whether MK-677 is effective in people who are frail and to assess its long-term safety.
This story originally appeared on the U.Va. Health System Web site.
osta-president
New member
Neonknight, the last time we checked into this, it was very expensive to synthesize and produce. It was just not a smart move for us. It was much higher than other peptides and almost the same as generic HGH. This about about 6 months ago and unless things have significantly changed I do not see us carrying this in the near future.
NeonKnight
New member
Thx osta.
How bout you GWP?
How bout you GWP?
Greatwhitepeptides
New member
we will look into it
Greatwhitepeptides
New member
We looked into us there is noway we could market this research chem due to the price sorry
NeonKnight
New member
how come gtgchem is selling it?
Greatwhitepeptides
New member
Look at the price 15ML for $100 if you research how much you need to take this compound is very expensive Also very very hard to suspend
We would rather bring better products that will sell and have high demand
you guys have a great company, please bring adipotide to the market and i will be your best buddy for life!!!
Greatwhitepeptides
New member
you guys have a great company, please bring adipotide to the market and i will be your best buddy for life!!!
WE are having it produced now it will come with HPLC reports also
man!!!!! i love you, you know that! god bless you!!
no need anymore for hardcore cardio, clen, ephedrine etc etc, this compound is truly amazing, in al it's actions.
i would take a bullet right now for you guys, really!!!!
Similar threads
